The stanley foundation bipolar network

British Journal of Psychiatry

Volumn 178, Issue SUPPL. 141, 2001, Pages

  Post, R M ^a   Nolen, W A ^a   Kupka, R W ^a   Denicoff, K D ^a   Leverich, G S ^a   Keck P E , Jr ^a   McElroy, S L ^a   Rush, A J ^a   Suppes, T ^a   Altshuler, L L ^a   Frye, M A ^a   Grunze, H ^a   Walden, J ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; SERTRALINE; VENLAFAXINE; TRANQUILIZER;

CONFERENCE PAPER; FINANCIAL MANAGEMENT; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RESEARCH; METHODOLOGY; PATIENT MONITORING; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; LONGITUDINAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTIMANIC AGENTS; BIPOLAR DISORDER; HUMANS; LONGITUDINAL STUDIES; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN;

EID: 17044450885     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.178.41.s169     Document Type: Conference Paper

References (47)

1. Gabapentin in the acute treatment of refractory bipolar disorder
2. A comparison of observational studies and randomised, controlled trials
3. Bipolar rapid cycling: Focus on depression as its hallmark
4. Randomized, controlled trials, observational studies, and a hierarchy of research designs
5. Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder
6. Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p)
7. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder
8. Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM™-p) for longitudinal assessment of bipolar illness
9. Increased platelet intracellular calcium concentration in patients with bipolar affective disorders
10. Baseline CSF somatostatin predictive of nimodipine treatment response
11. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders
12. The increasing polypharmacotherapy of refractory mood disorders: 22 years of study
13. Relapse and impairment in bipolar disorder
14. Course and outcome in bipolar affective disorder: A longitudinal follow up
15. A rating scale for depression
16. Elevated basal and thapsigargin stimulated intracellular calcium of platelet and lymphocytes from bipolar affective disorder patients measured by a fluorometric microassay
17. Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders
18. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism
19. The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments
20. Life charting the course of bipolar disorder
21. Life charting of affective disorders
22. The Stanley Foundation Bipolar Treatment Outcome Network: I. Longitudinal methodology
23. Olanzapine in treatment-resistant bipolar disorders
24. Open-label adjunctive topiramate in the treatment of bipolar disorder: A clinical case series
25. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder
26. Nimodipine increases CSF somatostatin in effectively ill patients
27. Speculations on the future of rTMS and related therapeutic modalities
28. Graphic representation of the life course of illness in patients with effective disorder
29. The role of complex combination therapy in the treatment of refractory bipolar illness
30. Beyond lithium in the treatment of bipolar illness
31. Special issues in trial design and use of placebo in bipolar illness
32. Carbamazepine and nimodipine in refractory effective illness: Efficacy and mechanisms
33. National Institute of Mental Health workshop on treatment of bipolar disorder
34. National Institute of Mental Health workshop report on the treatment of bipolar disorder
35. Factors associated with treatment success in lithium carbonate prophylaxis
36. The longitudinal course of recurrent effective illness: Life charting data from research patients at NIMH
37. The Inventory for Depressive Symptomatology (IDS): Preliminary findings
38. The Inventory of Depressive Sumptomatology (IDS): Psychometric properties
39. A double blind trial of bupropion versus desipramine for bipolar depression
40. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): The CGI-BP
41. Opposite effects of high and law frequency rTMS on regional brain activity in depressed patients
42. Life charting of the longitudinal course of recurrent effective illness
43. Omega-3 fatty acids in bipolar disorder: A preliminary double-blind, placebo-controlled trial
44. Lamotrigine for the treatment of bipolar disorder: A clinical case series
45. The Stanley Foundation Bipolar Treatment Outcome Network: II. Demographics and illness characteristics of the first 261 patients
46. A rating scale for mania: Reliability, validity and sensitivity